For Medicare beneficiaries aged 65 years and older, there is no evidence of elevated stroke risk immediately after vaccination with either brand of the COVID-19 bivalent vaccine, according to a study published in the March ...
Mar 21, 2024
0
1
U.S. flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says a University of Michigan researcher. Currently, all influenza vaccines in the United States are quadrivalent, ...
Feb 29, 2024
0
0
It happens every year around this time: The Centers for Disease Control and Prevention releases the new year's immunization schedules, which describe when and how vaccines should be given.
Jan 29, 2024
0
0
Hepatitis is inflammation in the liver caused by specific viruses. The hepatitis viruses are referred to as types A, B, C, D and E. All types affect the liver, but they differ in illness severity and prevention options.
Jan 25, 2024
0
3
Pregnant patients are more likely to accept COVID-19 vaccination if they receive other routine vaccines during pregnancy, according to a study published in the December issue of the Journal of Infection.
Jan 19, 2024
1
11
Following weeks of increases in flu activity, the latest U.S. government data shows "a single-week decrease" for the first time in months.
Jan 15, 2024
0
1
John Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physician friends, who hope their chiding might prevent him from becoming a statistic.
Jan 8, 2024
0
0
Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers ...
Dec 22, 2023
0
1
Low vaccination rates for the flu, RSV and COVID-19 are putting Americans at higher risk for severe illness and hospitalization this winter, a new government alert warned Thursday.
Dec 15, 2023
1
14
A high-dose recombinant influenza vaccine is more effective than standard-dose vaccine among adults aged 50 to 64 years, according to a study published in the Dec. 14 issue of the New England Journal of Medicine.
Dec 14, 2023
0
4
